ACEIs	Angiotensin-converting enzyme inhibitors
AEs	Adverse events
ARBs	Angiotensin-receptor blockers
CI	Confidence Intervals
CKD	Chronic kidney disease
DAAs	Direct-acting antiviral agents
DCV	Daclatasvir
3D	Ritonavir-boosted paritaprevir/ombitasvir/dasabuvir
EBR	Elbasvir
eGFR	Estimated glomerular filtration rate
ESRD	End-stage renal disease
FDV	Faldaprevir
GRZ	Grazoprevir
GN	Glomerulonephritis
HBV	Hepatitis B virus
HCV	Hepatitis C virus
HIV	Human immunodeficiency virus
HD	Haemodialysis
MCS	Mixed cryoglobulinemia syndrome
MPGN	Membranoproliferative glomerulonephritis
IFN	Interferon
LDV	Ledipasvir
pegIFN	Pegylated interferon
RBV	Ribavirin
RF	Rheumatoid factor
RT	Renal transplant
RTX	Rituximab
SIM	Simeprevir
SOF	Sofosbuvir
SVR	Sustained virological response